1. Home
  2. MHH vs INM Comparison

MHH vs INM Comparison

Compare MHH & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mastech Digital Inc

MHH

Mastech Digital Inc

HOLD

Current Price

$7.43

Market Cap

89.7M

ML Signal

HOLD

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.30

Market Cap

7.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHH
INM
Founded
1986
1981
Country
United States
Canada
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.7M
7.7M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
MHH
INM
Price
$7.43
$1.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.1K
66.3K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.68
EPS
0.01
N/A
Revenue
$191,371,000.00
$4,942,633.00
Revenue This Year
N/A
N/A
Revenue Next Year
$9.07
N/A
P/E Ratio
$740.00
N/A
Revenue Growth
N/A
7.50
52 Week Low
$5.51
$0.58
52 Week High
$8.37
$2.50

Technical Indicators

Market Signals
Indicator
MHH
INM
Relative Strength Index (RSI) 46.47 36.87
Support Level $6.78 $1.03
Resistance Level $7.72 $1.40
Average True Range (ATR) 0.12 0.08
MACD -0.00 -0.01
Stochastic Oscillator 57.14 5.97

Price Performance

Historical Comparison
MHH
INM

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. The IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.

Share on Social Networks: